Explore the scientific proceedings of the International Max Planck Research School (IMPRS). Discover cutting-edge research, academic papers, and key findings.
Background: Emergency medicine physicians (EMP) treat 1 million patients with acute decompensated heart failure (ADHF) annually. After emergency department (ED) treatment, EMPs must determine the need for further intravenous loop diuretic (IVLD) ther...
Background:Osteosarcoma, the most prevalent primary bone cancer, disproportionally affects adolescents and young adults. Despite aggressive chemotherapeutics, prognosis remains poor, highlighting the need for novel therapeutics. Romidepsin, a histone...
Background:Thromboembolisms are common, life-threatening emergencies. Systemic hemorrhaging post-thrombolytic treatment is an adverse reaction, highlighting the need for safer clot-digesting therapeutics. Our research focuses on an endogenous fibrino...
Purpose: TGFβ2 has been found to be elevated in the trabecular meshwork (TM) of patients with primary open-angle glaucoma. TM cells treated with TGFβ2 form cross-linked actin networks (CLANs). These CLANs are a restructuring of the cells’ actin cytos...
Background/Objective: Acute kidney injury (AKI) is common in high-risk neonates and is associated with increased morbidity and mortality. Standardized programs to identify AKI exist only in a few institutions. The sustainability and clinical impact o...
Background and Hypothesis: Glaucoma is a group of optic neuropathies that affects approximately 76 million people worldwide. The main risk factor is elevated intraocular pressure (IOP) which predominantly affects retinal ganglion cells (RGC), resulti...
Background: In 2021, the Indiana University School of Medicine Department of Emergency Medicine developed a DEI checklist for residents presenting to their colleagues during weekly didactic sessions. The purpose of this present study is to evaluate t...
Showing 16 to 22 of 22 results
By Sciaria
By Sciaria
By Sciaria
By Sciaria
By Sciaria
By Sciaria